- Deerfield participated in 4 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $269,500,000 (averaging $67,375,000 per round).
- Homology Medicines: Venture capital (Series B) ($83.5M)
- Xeris Pharmaceuticals: Venture capital (Series C) ($41M)
- Shockwave Medical, Inc.: Venture capital (Series C) ($45M)
- Redmile Group
- Deerfield Management Company
- Vivo Capital
Want to see the complete list?